Skip to content
Agentic OS
Menu

Intelligence / Healthtech / PMA Approvals / Lenstec, INC.

Approvalsdevice change approved (PMA)23 Oct 2026

Lenstec, INC.

23 Oct 2026: Device change approved (PMA) · ClearView™ HD intraocular lens (IOL). Recorded in the openFDA device PMA data.

View the source record

Decided
23 Oct 2026
Device
ClearView™ HD intraocular lens (IOL)
Specialty
Ophthalmic
Type
Supplement (Normal 180 Day Track)
Reason
Change Design/Components/Specifications/Material
Reference
P200020 S013
Location
St. Petersburg, FL
What this signal means

A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.

  1. Cardiovascular leads with 53 of 120, then Pathology (15).
  2. 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Lenstec, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Ophthalmic

PMA Approvals

See all

Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.